2013Unpublished venueRequires access

ADME Pharmacogenomics in Drug Development

Liangfu Chen, Joseph W. Polli

Open publisher page 4 citations

Abstract

This chapter contains sections titled: Introduction Current ADME Pharmacogenomic Practices in Drug Development and Clinical Practices Current Pharmacogenomics Approaches and Methodologies Recent Advances in Pharmacogenomics of Membrane Transporters ADME Pharmacogenomics: Challenges and Opportunities Conclusion

About this research paper

What this paper is about

This chapter contains sections titled: Introduction Current ADME Pharmacogenomic Practices in Drug Development and Clinical Practices Current Pharmacogenomics Approaches and Methodologies Recent Advances in Pharmacogenomics of Membrane Transporters ADME Pharmacogenomics: Challenges and Opportunities Conclusion

Why it matters

OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

This chapter contains sections titled: Introduction Current ADME Pharmacogenomic Practices in Drug Development and Clinical Practices Current Pharmacogenomics Approaches and Methodologies Recent Advances in Pharmacogenomics of Membrane Transporters ADME Pharmacogenomics: Challenges and Opportunities Conclusion

Key concepts: Pharmacogenomics, ADME, Drug development, Pharmacology, Drug, Natural Product Research, Medicine, Computational biology

Related papers

Back to paper searchBrowse research topicsOriginal source
ADME Pharmacogenomics in Drug Development — Research Paper | ScholarLens